ClearPoint Neuro, Inc. Equity, Fair Value Disclosure
ClearPoint Neuro, Inc. (CLPT) had Equity, Fair Value Disclosure of $2.78 million as of 2010-11-30, per its 10-K filed 2018-03-21.
Discontinued › Notes › Fair Value Measures and Disclosures
us-gaap:EquityFairValueDisclosure · last filed 2018-03-21
- 2010-11-30: Equity, Fair Value Disclosure $2.78M.
| Period end | Equity, Fair Value Disclosure |
|---|---|
| 2010-11-30 | $2.78M 10-K · filed 2018-03-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |